VK

Vivek Kaler

Active Director Director DIN 01997485
DIN 01997485 First appointment Nov 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Total affiliations 8 Since Nov 2004
Shareholding value •••• Premium profile

About Vivek Kaler

Data last updated:

Vivek Kaler is a Director at Safe And Cure Superspecialities Hospital Private Limited (since 2018), Director at Shree Krishnam Yrv Buildcon Private Limited (since 2013) and Director at Tenfold Pharmaceuticals Private Limited (since 2005), and holds 5 more current directorships. The companies operate in Healthcare, Real Estate and Construction and Pharma. The 7 current companies with reported revenue have a combined latest revenue of ₹7.10 Cr; the largest is Safe And Cure Superspecialities Hospital Private Limited at ₹2.60 Cr (FY 2023).

DIN 01997485
Primary Designation Director
Industry Healthcare
First Appointment 10 Nov 2004
Oldest Company Age 32 yrs
Largest company Safe And Cure Superspecialities Hospital Private Limited · ₹2.60 Cr (FY 2023)
Combined revenue ₹7.10 Cr across 7 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jul 20182018₹2.60 Cr (FY 2023)Active
Director30 Apr 20132013₹2.43 Cr (FY 2024)Active
Director13 Sep 20052005₹86.7 Lakh (FY 2025)Active
Rex Pumps Private Limited U29120RJ2008PTC026161
Additional Director23 Jul 20122008₹84.6 Lakh (FY 2025)Active
Deevee Marbles Private Limited U14101RJ1994PTC008359
Director10 Nov 20041994₹34.7 Lakh (FY 2023)Active
Gallit Infra Private Limited U70109RJ2018PTC061073
Director01 May 20182018₹97,847 (FY 2024)Active
Frontline Infratech Private Limited U70101RJ2011PTC033910
Director20 Jan 20112011₹51,660 (FY 2023)Active
Yrv Buildcon Private Limited U45201RJ2012PTC041030
Director17 Dec 20122012Active

Directorship timeline

Open interactive timeline →
Deevee Marbles Private Limited
Tenfold Pharmaceuticals Private Limited
Rex Pumps Private Limited
Yrv Buildcon Private Limited
Premium access

Shareholding and investment profile for Vivek Kaler

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Kaler

Vivek Kaler currently holds 8 directorships: Safe And Cure Superspecialities Hospital Private Limited (Director, since 12 Jul 2018, revenue ₹2.60 Cr (FY 2023)); Shree Krishnam Yrv Buildcon Private Limited (Director, since 30 Apr 2013, revenue ₹2.43 Cr (FY 2024)); Tenfold Pharmaceuticals Private Limited (Director, since 13 Sep 2005, revenue ₹86.7 Lakh (FY 2025)); Rex Pumps Private Limited (Additional Director, since 23 Jul 2012, revenue ₹84.6 Lakh (FY 2025)); Deevee Marbles Private Limited (Director, since 10 Nov 2004, revenue ₹34.7 Lakh (FY 2023)); and 3 more.

Vivek Kaler was first appointed on 10 Nov 2004 as Director at Deevee Marbles Private Limited. The most recent appointment on record is 12 Jul 2018 at Safe And Cure Superspecialities Hospital Private Limited.

The 7 current companies of Vivek Kaler that report revenue have a combined latest revenue of ₹7.10 Cr: Safe And Cure Superspecialities Hospital Private Limited ₹2.60 Cr (FY 2023); Shree Krishnam Yrv Buildcon Private Limited ₹2.43 Cr (FY 2024); Tenfold Pharmaceuticals Private Limited ₹86.7 Lakh (FY 2025); Rex Pumps Private Limited ₹84.6 Lakh (FY 2025); Deevee Marbles Private Limited ₹34.7 Lakh (FY 2023); and 2 more.

The current boards of Vivek Kaler's companies include Hardeo Ram Kaler (Safe And Cure Superspecialities Hospital Private Limited), Radha Devi Kaler (Safe And Cure Superspecialities Hospital Private Limited), Sucheta Kaler (Safe And Cure Superspecialities Hospital Private Limited), Raj Kumar Golechha (Shree Krishnam Yrv Buildcon Private Limited), Satish Kumar Singodiya (Shree Krishnam Yrv Buildcon Private Limited), Sunil Singodiya (Shree Krishnam Yrv Buildcon Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available